357 related articles for article (PubMed ID: 9885309)
21. Complexation study of the anticancer agent EO-9 with 2-hydroxypropyl-beta-cyclodextrin.
Beijnen JH; van der Schoot SC; Nuijen B; Flesch FM; Gore A; Mirejovsky D; Lenaz L
Drug Dev Ind Pharm; 2008 Oct; 34(10):1130-9. PubMed ID: 18663657
[TBL] [Abstract][Full Text] [Related]
22. Characterization of beta-lapachone and methylated beta-cyclodextrin solid-state systems.
Cunha-Filho MS; Dacunha-Marinho B; Torres-Labandeira JJ; Martínez-Pacheco R; Landín M
AAPS PharmSciTech; 2007 Jul; 8(3):E60. PubMed ID: 17915810
[TBL] [Abstract][Full Text] [Related]
23. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
Jug M; Bećirević-Laćan M
Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
[TBL] [Abstract][Full Text] [Related]
24. Chitosan microspheres with hydrocortisone and hydrocortisone-hydroxypropyl-beta-cyclodextrin inclusion complex.
Filipović-Grcić J; Voinovich D; Moneghini M; Becirevic-Lacan M; Magarotto L; Jalsenjak I
Eur J Pharm Sci; 2000 Feb; 9(4):373-9. PubMed ID: 10664477
[TBL] [Abstract][Full Text] [Related]
25. Interactions of griseofulvin with cyclodextrins in solid binary systems.
Veiga MD; Díaz PJ; Ahsan F
J Pharm Sci; 1998 Jul; 87(7):891-900. PubMed ID: 9649360
[TBL] [Abstract][Full Text] [Related]
26. Physical properties of the complexes formed between heptakis(2,6-di-O-methyl)-beta-cyclodextrin, beta-cyclodextrin, and chlorambucil.
Green AR; Miller ES; Guillory JK
J Pharm Sci; 1991 Feb; 80(2):186-9. PubMed ID: 2051328
[TBL] [Abstract][Full Text] [Related]
27. Improving the solubility of vorinostat using cyclodextrin inclusion complexes: The physicochemical characteristics, corneal permeability and ocular pharmacokinetics of the drug after topical application.
Yang J; Ma Y; Luo Q; Liang Z; Lu P; Song F; Zhang Z; Zhou T; Zhang J
Eur J Pharm Sci; 2022 Jan; 168():106078. PubMed ID: 34838620
[TBL] [Abstract][Full Text] [Related]
28. Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide.
Elgindy N; Elkhodairy K; Molokhia A; Elzoghby A
Eur J Pharm Biopharm; 2010 Feb; 74(2):397-405. PubMed ID: 19944160
[TBL] [Abstract][Full Text] [Related]
29. Influence of piroxicam: hydroxypropyl-beta-cyclodextrin complexation on the in vitro permeation and skin retention of piroxicam.
Doliwa A; Santoyo S; Ygartua P
Skin Pharmacol Appl Skin Physiol; 2001; 14(2):97-107. PubMed ID: 11316968
[TBL] [Abstract][Full Text] [Related]
30. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies.
Phillip Lee YH; Sathigari S; Jean Lin YJ; Ravis WR; Chadha G; Parsons DL; Rangari VK; Wright N; Babu RJ
Drug Dev Ind Pharm; 2009 Sep; 35(9):1113-20. PubMed ID: 19640249
[TBL] [Abstract][Full Text] [Related]
31. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
32. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
33. Dual Activity of Hydroxypropyl-β-Cyclodextrin and Water-Soluble Carriers on the Solubility of Carvedilol.
Zoghbi A; Geng T; Wang B
AAPS PharmSciTech; 2017 Nov; 18(8):2927-2935. PubMed ID: 28432614
[TBL] [Abstract][Full Text] [Related]
34. Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-beta-cyclodextrin.
Choi HG; Kim DD; Jun HW; Yoo BK; Yong CS
Drug Dev Ind Pharm; 2003 Nov; 29(10):1085-94. PubMed ID: 14677769
[TBL] [Abstract][Full Text] [Related]
35. Encapsulation of thiabendazole in hydroxypropyl-β-cyclodextrin nanofibers via polymer-free electrospinning and its characterization.
Gao S; Liu Y; Jiang J; Li X; Zhao L; Fu Y; Ye F
Pest Manag Sci; 2020 Sep; 76(9):3264-3272. PubMed ID: 32378331
[TBL] [Abstract][Full Text] [Related]
36. The novel application of tertiary butyl alcohol in the preparation of hydrophobic drug-HPbetaCD complex.
Wang Z; Deng Y; Zhang X
J Pharm Pharmacol; 2006 Mar; 58(3):409-14. PubMed ID: 16536910
[TBL] [Abstract][Full Text] [Related]
37. Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.
Ribeiro A; Figueiras A; Santos D; Veiga F
AAPS PharmSciTech; 2008; 9(4):1102-9. PubMed ID: 18975116
[TBL] [Abstract][Full Text] [Related]
38. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.
Fernandes CM; Teresa Vieira M; Veiga FJ
Eur J Pharm Sci; 2002 Feb; 15(1):79-88. PubMed ID: 11803134
[TBL] [Abstract][Full Text] [Related]
39. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
[TBL] [Abstract][Full Text] [Related]
40. Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin.
Mummidi V; Jayanthi V
Drug Dev Ind Pharm; 2013 Jul; 39(7):970-7. PubMed ID: 22612875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
